BioCentury
ARTICLE | Company News

Emisphere, Novo Nordisk deal

May 6, 2013 7:00 AM UTC

Emisphere and Novo Nordisk amended a 2008 deal granting Novo Nordisk an exclusive license to use Emisphere's Eligen drug delivery technology to develop and commercialize oral formulations of Novo Nord...